|
Brucellosis, Bovine
|
C22.021.322 |
|
|
1-Pyrroline-5-Carboxylate Dehydrogenase
|
D08.811.682.662.693 |
|
|
Usher Syndromes
|
C10.597.751.941.162.625.500 |
|
|
Tretinoin
|
D02.455.426.392.368.367.379.249.700.860.500 |
|
|
Cardiomyopathy, Dilated
|
C16.320.488.750 |
|
|
Gold
|
D01.268.956.186 |
|
|
Synaptophysin
|
D12.776.631.800 |
|
|
Peroxynitrous Acid
|
D01.625.700.750 |
|
|
Antioxidant Response Elements
|
G05.360.080.689.675.700.040 |
|
|
Potentially Inappropriate Medication List
|
N05.700.594 |
|
|
Epitestosterone
|
D06.472.334.851.968.984.500 |
|
|
Rectocele
|
C06.405.469.860.810 |
|
|
Electronic Nose
|
E07.230.210 |
|
|
Arnold-Chiari Malformation
|
C10.500.680.291 |
|
|
Contraindications, Procedure
|
E02.208.600 |
|
|
Contraindications
|
E02.208 |
|
|
Myasthenia Gravis
|
C10.114.656 |
|
|
Copper
|
D01.268.956.170 |
|
|
Endoscopes
|
E07.230.220 |
|
|
Interleukin-8
|
D23.529.374.200.120.800 |
|
